NXTC
NXTC
NASDAQ · Biotechnology

Nextcure Inc

$10.01
-0.12 (-1.18%)
As of Mar 29, 10:51 PM ET ·
Financial Highlights (FY 2025)
Revenue
6.98M
Net Income
-1,326,181
Gross Margin
34.1%
Profit Margin
-19.0%
Rev Growth
+10.9%
D/E Ratio
0.21
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 34.1% 34.1% 34.1%
Operating Margin -22.6% -24.7% -23.9%
Profit Margin -19.0% -22.1% -20.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.98M 7.00M 7.72M
Gross Profit 2.38M 2.38M 2.63M
Operating Income -1,576,138 -1,727,492 -1,843,802
Net Income -1,326,181 -1,545,557 -1,571,652
Gross Margin 34.1% 34.1% 34.1%
Operating Margin -22.6% -24.7% -23.9%
Profit Margin -19.0% -22.1% -20.4%
Rev Growth +10.9% +1.3% +2.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.62M 4.77M 6.06M
Total Equity 26.87M 26.41M 26.59M
D/E Ratio 0.21 0.18 0.23
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,878,590 -1,945,549 -2,406,257
Free Cash Flow -1,092,947 -1,597,568 -1,077,092